Indication
mesenchymal stem cells
4 clinical trials
4 products
Clinical trial
Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (Allo-hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND)Status:
Clinical trial
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation to Enhance Islet Survival and Function in Chronic Pancreatitis Patients Undergo Total Pancreatectomy and Islet AutotransplantationStatus: Recruiting, Estimated PCD: 2026-06-30
Clinical trial
An Open-label, Non-randomized, Phase I Study of Allogeneic Placenta Derived Mesenchymal Stem Cells in Patients With Secondary-Progressive Multiple Sclerosis (SPMS),Status: Completed, Estimated PCD: 2024-03-04
Clinical trial
Phase I/II Randomized Controlled Trial of Umbilical Cord-derived mesenChymAl stRomal cElls in Systemic SclerosisStatus: Recruiting, Estimated PCD: 2024-12-01
Product
UCMSC